查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1485767

奈米藥物市場，依形態、依應用、依適應症、依分子類型、依國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Nanomedicines Market, By Modality, By Application, By Indication, By Molecule Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年奈米藥物市場規模為2.3104億美元，2024年至2032年複合年成長率為12.92%。

奈米藥物市場-市場動態

奈米技術在藥物傳輸方法的應用迅速增加，以推動市場需求

基於奈米技術的藥物傳輸方法的採用正在快速成長，這得益於其在靶向輸送、增強藥物療效和減少副作用方面所提供的優勢。這種成長的推動因素包括研發投資的增加、奈米材料和藥物傳輸技術的進步以及對個人化和精準醫療解決方案不斷成長的需求。此外，隨著基於奈米醫學的疫苗和治療方法的開發來對抗病毒，COVID-19大流行進一步加速了奈米技術在藥物傳輸中的採用。

奈米藥物市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 12.92% 左右的複合年成長率成長

根據模式區隔，治療預計將在 2023 年顯示最大的市場佔有率

從應用區隔來看，2023年藥物傳遞是主導類型

基於適應症區隔，心血管

是2023年的主導類型

依地區分類，北美是 2023 年的主要收入來源

奈米藥物市場-區隔分析：

全球奈米藥物市場根據形態、應用、適應症、分子類型和區域進行區隔。

根據形式，市場分為兩類： 治療涉及使用奈米藥物進行治療，針對特定疾病或醫療狀況。診斷通常透過先進的成像或檢測方法利用奈米技術來診斷疾病或病症。

根據應用，市場分為兩類：藥物輸送專注於使用奈米藥物進行標靶藥物輸送，增強藥物療效並最大限度地減少副作用。 IVD 利用奈米技術在體外進行診斷測試，例如血液測試或基因測試。植入物涉及在醫療植入物（例如骨科植入物或牙科植入物）中使用奈米材料，以提高生物相容性和性能。

奈米藥物市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

北美和歐洲是關鍵參與者，擁有先進的研究基礎設施、健全的監管框架以及對奈米醫學研究和開發的大量投資。同時，在醫療保健支出增加、慢性病盛行率增加以及創新療法普及的推動下，亞太地區展現出巨大的成長潛力。拉丁美洲以及中東和非洲地區也提供了市場擴張的機會，儘管面臨醫療基礎設施、負擔能力和監管複雜性的課題。

奈米藥物市場-競爭格局：

一些關鍵參與者正在透過研發投資、併購和策略合作夥伴關係等策略主導市場。雅培（Abbott Laboratories）、強生（Johnson & Johnson）和輝瑞（Pfizer）等公司憑藉多樣化的奈米醫學產品組合和廣泛的全球影響力引領市場。此外，安進（Amgen）、吉利德科學（Gilead Sciences）和諾華（Novartis）等創新生物技術公司透過突破性療法和新型候選藥物為市場競爭力做出了貢獻。隨著競爭的加劇，企業專注於透過產品創新、法規核准和市場擴張努力來實現差異化。

最近的發展：

2022 年 1 月，輝瑞公司和 Acuitas Therapeutics 披露了一項開發和選擇協議，其中輝瑞將有機會獲得 Acuitas 的 LNP 技術許可，以非獨家的方式用於疫苗或治療開發的多達 10 個目標。

目錄

第1章：奈米藥物市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 依形態分類的奈米藥物市場片段
    • 奈米藥物市場片段（依應用）
    • 依適應症分類的奈米藥物市場片段
    • 依分子類型分類的奈米藥物市場片段
    • 依國家/地區分類的奈米藥物市場摘要
    • 依地區分類的奈米藥物市場片段
  • 競爭洞察

第 3 章：奈米藥物主要市場趨勢

  • 奈米藥物市場促進因素
    • 市場促進因素的影響分析
  • 奈米藥物市場限制
    • 市場限制影響分析
  • 奈米藥物市場機會
  • 奈米藥物市場未來趨勢

第 4 章：奈米藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：奈米藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：奈米藥物市場格局

  • 2023 年奈米藥物市場佔有率分析
  • 依主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：奈米藥物市場 - 依形態

  • 概述
    • 依方式分類的區隔市場佔有率分析
    • 治療
    • 診斷

第 8 章：奈米藥物市場 - 依應用

  • 概述
    • 依應用分類的區隔市場佔有率分析
    • 藥物輸送
    • 體外診斷
    • 注入
    • 疫苗
    • 其他

第 9 章：奈米藥物市場 - 依適應症

  • 概述
    • 依指標分類的區隔市場佔有率分析
    • 腫瘤學
    • 傳染性
    • 心血管
    • 神經病學

第 10 章：奈米藥物市場 - 依分子類型

  • 概述
    • 依應用分類的區隔市場佔有率分析
    • 奈米粒子
    • 奈米管
    • 奈米裝置

第 11 章：奈米藥物市場 - 依地理位置

  • 介紹
    • 依地理位置分類的區隔市場佔有率分析
  • 北美洲
    • 概述
    • 北美奈米藥物主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依方式）
    • 北美市場規模和預測（依應用）
    • 北美市場規模和預測（依指標）
    • 北美市場規模和預測（依分子類型）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲奈米藥物主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模與預測（依方式）
    • 歐洲市場規模和預測（依應用）
    • 歐洲市場規模與預測（依指標）
    • 歐洲市場規模和預測（依分子類型）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區奈米藥物主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依方式）
    • 亞太地區市場規模與預測（依應用）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模與預測（依分子類型）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲奈米藥物主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依方式）
    • 拉丁美洲市場規模與預測（依應用）
    • 拉丁美洲市場規模與預測（依指標）
    • 拉丁美洲市場規模與預測（依分子類型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲奈米藥物主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依方式）
    • 中東和非洲市場規模及預測（依應用）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模及預測（依分子類型）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 奈米藥物產業

  • 競爭儀表板
  • 公司簡介
    • Sanofi SA
    • Celgene Corporation
    • Nanobiotix
    • Luminex Corporation
    • Nanospectra Biosciences Inc
    • NanoCarrier Co. Ltd
    • Johnson & Johnson Services Inc
    • Merck & Co., Inc
    • Pfizer, Inc.
    • NanoCarrier Co. Ltd
    • Taiwan Liposome Company Ltd
    • Hoffmann-La Roche AG (Roche)
    • Gilead Science Inc
    • Ipsen SA.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2665

REPORT HIGHLIGHT

Nanomedicines Market size was valued at USD 231.04 Million in 2023, expanding at a CAGR of 12.92% from 2024 to 2032.

The nanomedicine market encompasses the use of nanotechnology for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications. The development of personalized nanomedicines tailored to individual patient profiles, and increasing research focus on combination therapies and multifunctional nanoplatforms. However, restraints in the nanomedicine market include challenges related to regulatory approvals and safety concerns associated with nanomaterials. Opportunities abound in the integration of nanotechnology with other emerging technologies like artificial intelligence and gene editing for precision medicine approaches.

Nanomedicines Market- Market Dynamics

Rapidly increasing utilization of nanotechnology in drug delivery methods to propel market demand

The adoption of nanotechnology-based methods for drug delivery is experiencing rapid growth, driven by the advantages offered in terms of targeted delivery, enhanced drug efficacy, and reduced side effects. This growth is fueled by increasing investments in research and development, advancements in nanomaterials and drug delivery technologies, and a rising demand for personalized and precision medicine solutions. Additionally, the COVID-19 pandemic has further accelerated the adoption of nanotechnology in drug delivery, with the development of nanomedicine-based vaccines and therapeutics to combat the virus.

Nanomedicines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.92% over the forecast period (2024-2032)

Based on Modality segmentation, Treatment was predicted to show maximum market share in the year 2023

Based on application segmentation, Drug Delivery was the leading type in 2023

Based on Indication segmentation, Cardiovascular

was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanomedicines Market- Segmentation Analysis:

The Global Nanomedicines Market is segmented on the basis of Modality, Application, Indication, Molecule Type, and Region.

The market is divided into two categories based on Modality: Treatment involves the use of nanomedicines for therapeutic purposes, targeting specific diseases or medical conditions. Diagnostics utilizes nanotechnology for diagnosing diseases or conditions, often through advanced imaging or detection methods.

The market is divided into two categories based on application: Drug Delivery focuses on the use of nanomedicines for targeted drug delivery, enhancing drug efficacy, and minimizing side effects. IVD utilizes nanotechnology for diagnostic tests performed outside the body, such as blood tests or genetic testing. An implant involves the use of nanomaterials in medical implants, such as orthopedic implants or dental implants, to improve biocompatibility and performance.

Nanomedicines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced research infrastructure, robust regulatory frameworks, and significant investments in nanomedicine research and development. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Nanomedicines Market- Competitive Landscape:

Several key players are dominaning the market through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies like Abbott Laboratories, Johnson & Johnson, and Pfizer lead the market with diverse portfolios of nanomedicine products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Gilead Sciences, and Novartis contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In January 2022, Pfizer Inc. and Acuitas Therapeutics disclosed a development and option agreement, wherein Pfizer will hold the opportunity to license Acuitas' LNP technology for potential utilization in up to ten targets for vaccine or therapeutic development on a non-exclusive basis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMEDICINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Sanofi SA

Celgene Corporation

Nanobiotix

Luminex Corporation

Nanospectra Biosciences Inc

NanoCarrier Co. Ltd

Johnson & Johnson Services Inc

Merck & Co., Inc

Pfizer, Inc.

NanoCarrier Co. Ltd

Taiwan Liposome Company Ltd

Hoffmann-La Roche AG (Roche)

Gilead Science Inc

Ipsen SA.

Others

GLOBAL NANOMEDICINES MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Treatment
  • Diagnostics

GLOBAL NANOMEDICINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • IVD
  • Implant
  • Vaccine
  • Others

GLOBAL NANOMEDICINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Infectious
  • Cardiovascular
  • Neurological

GLOBAL NANOMEDICINES MARKET, BY MOLECULE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanoparticle
  • Nanotube
  • Nanodevice

GLOBAL NANOMEDICINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Nanomedicines Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Nanomedicines Market Snippet by Modality
    • 2.1.2.Nanomedicines Market Snippet by Application
    • 2.1.3.Nanomedicines Market Snippet by Indication
    • 2.1.4.Nanomedicines Market Snippet by Molecule Type
    • 2.1.5.Nanomedicines Market Snippet by Country
    • 2.1.6.Nanomedicines Market Snippet by Region
  • 2.2.Competitive Insights

3.Nanomedicines Key Market Trends

  • 3.1.Nanomedicines Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Nanomedicines Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Nanomedicines Market Opportunities
  • 3.4.Nanomedicines Market Future Trends

4.Nanomedicines Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Nanomedicines Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Nanomedicines Market Landscape

  • 6.1.Nanomedicines Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Nanomedicines Market - By Modality

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Modality, 2023 & 2032 (%)
    • 7.1.2.Treatment
    • 7.1.3.Diagnostics

8.Nanomedicines Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Drug Delivery
    • 8.1.3.IVD
    • 8.1.4.Implant
    • 8.1.5.Vaccine
    • 8.1.6.Others

9.Nanomedicines Market - By Indication

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Infectious
    • 9.1.4.Cardiovascular
    • 9.1.5.Neurological

10.Nanomedicines Market - By Molecule Type

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Nanoparticle
    • 10.1.3.Nanotube
    • 10.1.4.Nanodevice

11.Nanomedicines Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Nanomedicines Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Nanomedicines Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Nanomedicines Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Nanomedicines Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Nanomedicines Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Nanomedicines Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Sanofi SA
    • 12.2.2.Celgene Corporation
    • 12.2.3.Nanobiotix
    • 12.2.4.Luminex Corporation
    • 12.2.5.Nanospectra Biosciences Inc
    • 12.2.6.NanoCarrier Co. Ltd
    • 12.2.7.Johnson & Johnson Services Inc
    • 12.2.8.Merck & Co., Inc
    • 12.2.9.Pfizer, Inc.
    • 12.2.10.NanoCarrier Co. Ltd
    • 12.2.11.Taiwan Liposome Company Ltd
    • 12.2.12.Hoffmann-La Roche AG (Roche)
    • 12.2.13.Gilead Science Inc
    • 12.2.14.Ipsen SA.
    • 12.2.15.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanomedicines Market: Modality Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Modality
  • TABLE Global Nanomedicines Market, by Modality 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanomedicines Market, by Application 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Nanomedicines Market, by Indication 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Molecule Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Molecule Type
  • TABLE Global Nanomedicines Market, by Molecule Type 2019-2032 (USD Million)
  • TABLE Nanomedicines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanomedicines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Modality, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)